Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes

Two recent studies published in Nature focused on the clinical efficacy of the menin inhibitor revumenib (SNDX-5613) in KMT2A (histone-lysine N-methyltransferase 2A)-rearranged or NPM1 (Nucleophosmin1)-mutant acute myeloid leukemia.1,2 These studies indicate that menin inhibition and its acquired re...

Full description

Bibliographic Details

Main Author:	Di Fazio, Pietro
Format:	Article
Language:	English
Published:	Philipps-Universität Marburg 2024
Subjects:	Drug development Medizin Haematological cancer Molecular medicine Medical sciences Medicine
Online Access:	PDF Full Text
Tags:	Add Tag No Tags, Be the first to tag this record!